Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasms.
Shibamiya A, Miyamoto-Nagai Y, Koide S, Oshima M, Rizq O, Aoyama K, Nakajima-Takagi Y, Kato R, Kayamori K, Isshiki Y, Oshima-Hasegawa N, Muto T, Tsukamoto S, Takeda Y, Koyama-Nasu R, Chiba T, Honda H, Yokote K, Iwama A, Sakaida E, Mimura N. Shibamiya A, et al. Among authors: koyama nasu r. Cancer Immunol Immunother. 2023 Aug;72(8):2635-2648. doi: 10.1007/s00262-023-03447-x. Epub 2023 Apr 17. Cancer Immunol Immunother. 2023. PMID: 37069353 Free PMC article.
CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy.
Hara A, Koyama-Nasu R, Takami M, Toyoda T, Aoki T, Ihara F, Kobayashi M, Hirono S, Matsutani T, Nakayama T, Iwadate Y, Motohashi S. Hara A, et al. Among authors: koyama nasu r. Cancer Immunol Immunother. 2021 May;70(5):1239-1254. doi: 10.1007/s00262-020-02742-1. Epub 2020 Oct 31. Cancer Immunol Immunother. 2021. PMID: 33128583 Free PMC article.
CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes.
Koyama-Nasu R, Kimura MY, Kiuchi M, Aoki A, Wang Y, Mita Y, Hasegawa I, Endo Y, Onodera A, Hirahara K, Motohashi S, Nakayama T. Koyama-Nasu R, et al. Cancer Immunol Res. 2023 Aug 3;11(8):1085-1099. doi: 10.1158/2326-6066.CIR-22-0406. Cancer Immunol Res. 2023. PMID: 37216576
A new therapeutic target: the CD69-Myl9 system in immune responses.
Kimura MY, Koyama-Nasu R, Yagi R, Nakayama T. Kimura MY, et al. Among authors: koyama nasu r. Semin Immunopathol. 2019 May;41(3):349-358. doi: 10.1007/s00281-019-00734-7. Epub 2019 Apr 5. Semin Immunopathol. 2019. PMID: 30953160 Review.
Essential Role for CD30-Transglutaminase 2 Axis in Memory Th1 and Th17 Cell Generation.
Suzuki AS, Yagi R, Kimura MY, Iwamura C, Shinoda K, Onodera A, Hirahara K, Tumes DJ, Koyama-Nasu R, Iismaa SE, Graham RM, Motohashi S, Nakayama T. Suzuki AS, et al. Among authors: koyama nasu r. Front Immunol. 2020 Jul 21;11:1536. doi: 10.3389/fimmu.2020.01536. eCollection 2020. Front Immunol. 2020. PMID: 32793209 Free PMC article.
IFNγ suppresses the expression of GFI1 and thereby inhibits Th2 cell proliferation.
Sarkar MH, Yagi R, Endo Y, Koyama-Nasu R, Wang Y, Hasegawa I, Ito T, Junttila IS, Zhu J, Kimura MY, Nakayama T. Sarkar MH, et al. Among authors: koyama nasu r. PLoS One. 2021 Nov 22;16(11):e0260204. doi: 10.1371/journal.pone.0260204. eCollection 2021. PLoS One. 2021. PMID: 34807911 Free PMC article.
27 results